Horizon制药公共 HZNP 深 沪
已收盘 10-06 16:00:00 美东时间
116.30
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 116.30
- 总市值 266.33亿
- 52周最高 116.38
- 市盈率 静 52.46
- 换手率 0.00%
- 52周最低 60.03
- 委 比 0.00%
- 总股本 2.29亿
- 历史最高 120.535
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.965
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Ast...
10-18 04:00
Horizon Bank Appoints Larry S. Magnesen to Serve as Independent Director
Horizon Bancorp, Inc. announces the appointment of Larry S. Magnesen as an independent director, effective October 10, 2025. With over 40 years in banking, Magnesen previously held senior roles at Fifth Third Bank and other financial institutions. He will join Horizon’s Board, contributing to key committees and leveraging his expertise to support the company's growth in the Midwest. Horizon Bancorp, with $7.7 billion in assets, provides banking a...
10-14 20:05
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenN...
10-06 21:00
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
THOUSAND OAKS, Calif., Sept. 26, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. The plan...
09-26 21:00
默沙东、辉瑞、诺和诺德，宣布减员计划
在美国特朗普政府不确定的政策影响下，今年全球制药行业在资本市场的表现低迷，关税及药品价格下调等因素导致企业成本压力上升。在近期公布的第二季度财报中，多家制药企业...
08-21 19:28
Galapagos appoints Aaron Cox as CFO
Galapagos (OTCPK:GLPGF) has announced the appointment of Aaron Cox as CFO, effective July 7, 2025. Cox succeeds Thad Huston, who will remain with the company through July 31, 2025, to ensure a smooth ...
06-23 14:35
2024 年全球大型药企薪酬最高十位 CEO
（转自：抗体圈） 尽管在 Fierce 的 2024 年制药公司首席执行官薪酬排行榜上出现了许多熟悉的名字，但多位高管的排名发生了巨大变化，而第一名被一位黑马候...
06-18 11:23
IMDELLTRA® SIGNIFICANTLY REDUCED RISK OF DEATH BY 40% IN SMALL CELL LUNG CANCER PATIENTS
Breakthrough Second-Line Treatment Demonstrated Survival Advantage over Standard-of-Care Chemotherapy Late-Breaking Data Presented at ASCO 2025 and Simultaneously Published in The New Engla...
06-02 20:04
Amgen’s Tepezza becomes first U.K.-medicine approved for adults with thyroid eye disease
The U.K. drug regulator on Wednesday approved Amgen’s (NASDAQ:AMGN) intravenous medication teprotumumab (Tepezza) as the country’s medicine indicated specifically for adults with moderate to severe th...
05-08 02:16
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the fi...
05-02 04:01
